+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-11-21Number of Pages: 72

Mouth Ulcers Treatment Market (By Formulation - Mouthwash, Gel, Spray, Lozenge; By Indication - Aphthous Stomatitis, Oral Lichen Planus, Others; By Drug Class - Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Mouth ulcers or sores are small lesions that mostly appear inside the mouth and are painful when eating, drinking or brushing. Mouth ulcers are not contagious and mostly heal within three weeks of the onset. A doctor’s advice is necessary if these last over three weeks. It has been observed that around 2% to 60% of the global population is suffering from various types of mouth ulcers. The global mouth ulcer treatment market is experiencing significant growth due to high prevalence rate and low cost of treatment procedures. Moreover, easy availability of the products for the treatment of mouth ulcers is one of the major factors supporting the growth of the market. However, steroid mouthwash cannot be used by children due to significant side effects and high failure rate of the clinical trial pipeline analysis of mouth ulcer products. This would hamper the growth of the market. The global mouth ulcers treatment market was valued at USD 1,242.6 million in 2013 and is expected to reach an estimated value of USD 1,596.9 million in 2020, growing at a CAGR of 3.8% from 2014 to 2020. 
 
Based on formulation, the mouth ulcers treatment market is segmented as mouthwash, gels, sprays and lozenges. In 2013, gels segment contributed the largest market share of the global market owing to easy availability in all leading medical stores coupled with rising preference by healthcare professionals. Likewise, lozenges formulation segment is expected to grow at the highest growth rate during the forecast period from 2014 to 2020. This growth was mainly attributed to increasing number of companies entering into development and manufacturing of lozenges. For instance, Combe Incorporated manufactures Cepacol Fizzlers, which is anesthetic in nature. Similarly, Blistex Inc. has also entered into the production of lozenges under the brand name Kank-a.  
 
Aphthous stomatitis indication segment accounted for the largest market share of the global mouth ulcers treatment market and is expected to grow at a highest rate during the forecast period from 2014 to 2020. Factors such as high prevalence rate and easily availability of treatment product are supporting the growth of this market segment. The International Journal of Health and Nutrition published in 2013 that the prevalence of aphthous stomatitis ranged from 2% to 60% among the global population. Likewise, corticosteroid is the first line of treatment for mouth ulcers. Hence, it contributed the largest market share in 2013 and is expected to grow at a highest CAGR from 2014 to 2020. Dominance of this market segment is mostly attributed to faster healing, highly effective treatment, quick recovery from the ulcer pain and available in all formulations such as mouthwash, gels, sprays and lozenges.  
 
Geographically, North America was the largest market for mouth ulcers treatment in 2013 and is anticipated to maintain its dominance by the end of 2020. Dominance of North American region in this market was witnessed due to increasing awareness among people about mouth ulcers, high prevalence rate of mouth ulcers and rising demand for mouth ulcers treatment. Europe accounted for the second largest share in the global mouth ulcers treatment market. Geriatric are the potential population primarily driving the mouth ulcers treatment market in Europe.  
 
Asia-Pacific is expected to grow at the highest CAGR from 2014 to 2020. This growth was mainly attributed to rising incidences of mouth ulcers coupled with favorable government initiatives are expected to boost the market for mouth ulcers treatment. For instance, Annals of Clinical Psychiatry in 2013 stated, around 51.0% people were diagnosed with recurrent aphthous stomatitis in Asia. Lozenge segment is the most lucrative segment in the region owing to easy availability and low cost of the product. Likewise, gel formulation accounted for the largest market share in 2013, as most of the doctors and pharmacists preferred gel as a first line treatment for mouth ulcers in Asian countries. Major players operating in this market include 3M Healthcare, Bristol Meyer Squibb Company, ECR Pharmaceuticals, GlaxoSmithKline plc and Church & Dwight Co, Inc. 

Chapter 1 Introduction
1.1 Market Segmentation
1.2 Research Methodology
      1.2.1 Secondary Research
      1.2.2 Primary Research
      1.2.3 Models
      1.2.4 Assumptions
1.3 List of Abbreviations
 
Chapter 2 Executive Summary
2.2 Global Mouth Ulcers Treatment Market, by Drug Class, 2013 (USD Million)
2.3 Comparative Analysis: Global Mouth Ulcers Treatment Market, by Geography, 2013 and 2020 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
      3.2.1 Increasing awareness about mouth ulcers primarily accentuates the market growth
      3.2.2 Aging population propels the demand for mouth ulcers treatment products
3.3 Market Restraints
      3.3.1 Side effects pose threat to the growth of this market
3.4 Market Opportunities
      3.4.1 Asia Pacific holds immense growth potential in mouth ulcers treatment
3.5 Value Chain Analysis
3.6 Porter’s Five Forces Analysis: Global Mouth Ulcers Treatment Market
      3.6.1 Bargaining power of suppliers
      3.6.2 Bargaining power of buyers
      3.6.3 Threat of new entrants
      3.6.4 Threat of Substitutes
      3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis: Global Mouth Ulcers Treatment Market, by Geography
3.8 Heat Map Analysis for Key Market Players
      3.8.1 Heat Map Analysis of the Mouth Ulcers Treatment Market, by Key Market Players, 2013
               3.8.1.1 3M Health Care
               3.8.1.2 Taro Pharmaceutical Industries Ltd.
 
Chapter 4 Mouth Ulcers Treatment Market, by Drug Class
4.1 Overview
      4.1.1 Global Mouth Ulcer Treatments Market Revenue, by Formulation, 2012 - 2020 (USD Million)
4.2 Mouthwash
      4.2.1 Global Mouthwashes Market Revenue, 2012 - 2020 (USD Million)
4.3 Gels
      4.3.1 Global Gels Market Revenue, 2012 - 2020 (USD Million)
4.4 Sprays
      4.4.1 Global Sprays Market Revenue, 2012 - 2020 (USD Million)
4.5 Lozenges
      4.5.1 Global Lozenges Market Revenue, 2012 - 2020 (USD Million)
 
Chapter 5 Mouth Ulcer Treatment Market, by Indication
5.1 Overview
      5.1.1 Global Mouth Ulcer Treatments Market Revenue, by Indication, 2012 - 2020 (USD Million)
5.2 Aphthous Stomatitis
      5.2.1 Global Aphthous Stomatitis Market Revenue, 2012 - 2020 (USD Million)
5.3 Oral Lichen Planus
      5.3.1 Global Oral Lichen Planus Market Revenue, 2012 - 2020 (USD Million)
5.4 Others
      5.4.1 Global Others Market Revenue, 2012 - 2020 (USD Million)
 
Chapter 6 Mouth Ulcers Treatment Market, by Drug Class
6.1 Overview
      6.1.1 Global Mouth Ulcer Treatments Market Revenue, by Drug Class, 2012 - 2020 (USD Million)
6.2 Corticosteroids
      6.2.1 Global Corticosteroid Market Revenue, 2012 - 2020 (USD Million)
6.3 Anesthetics
      6.3.1 Global Anesthetic Market Revenue, 2012 - 2020 (USD Million)
6.4 Analgesics
      6.4.1 Global Analgesic Market Revenue, 2012 - 2020 (USD Million)
6.5 Antihistamines
      6.5.1 Global Antihistamine Market Revenue, 2012 - 2020 (USD Million)
6.6 Antimicrobials
      6.6.1 Global Antimicrobial Market Revenue, 2012 - 2020 (USD Million)
 
Chapter 7 Mouth Ulcers Treatment Market, by Geography
7.1 Overview
      7.1.1 Global Mouth Ulcers Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)
7.2 North America
      7.2.1 North America Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
7.3 Europe
      7.3.1 Europe Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
7.4 Asia-Pacific
      7.4.1 Asia-Pacific Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
7.5 Rest of the World
      7.5.1 RoW Mouth Ulcers treatment Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 8 Recommendations
8.1 Market Strategy for Success
      8.1.1 Investing in emerging markets to gain market share
      8.1.2 Mergers and acquisitions for sufficient market expansion
      8.1.3 Develop innovative product that ensures less side effect
 
Chapter 9 Company Profiles
9.1 3M
      9.1.1 Company overview
      9.1.2 Financial overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.7 Recent Developments
9.2 BLISTEX, INC.
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
9.3 Bristol-Myers Squibb Company
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Church & Dwight Co., Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.6 Recent Developments
9.5 The Colgate-Palmolive Company
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.6 Recent Developments
9.6 ECR Pharmaceuticals
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Recent Developments
9.7 GlaxoSmithKline plc
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.7 Recent Developments
9.8 Pfizer, Inc.
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.7 Recent Developments
9.9 Taro Pharmaceutical Industries Ltd.
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio      
      9.9.4 Business Strategies
      9.9.6 Recent Developments

List of Figures
 
FIG. 1 Mouth Ulcers Treatment : Market Segmentation
FIG. 2 Global Mouth Ulcers Treatment Market, by Drug Class, 2013 (USD Million)
FIG. 3 Comparative Analysis: Global Mouth Ulcers Treatment Market, by Geography, 2013 & 2020 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Mouth Ulcers Treatment Market
FIG. 6 Market Attractiveness Analysis: Global Mouth Ulcers Treatment Market, by Geography, 2013 Value (%)
FIG. 7 Heat Map Analysis of Key Market Players of the Mouth Ulcers Treatment Market
FIG. 7 Global Mouthwashes Market Revenue, 2012 - 2020 (USD Million)
FIG. 8 Global Gels Market Revenue, 2012 - 2020 (USD Million)
FIG. 9 Global Sprays Market Revenue, 2012 - 2020 (USD Million)
FIG. 10 Global Lozenges Market Revenue, 2012 - 2020 (USD Million)
FIG. 11 Global Aphthous Stomatitis Market Revenue, 2012 - 2020 (USD Million)
FIG. 12 Global Oral Lichen Planus Market Revenue, 2012 - 2020 (USD Million)
FIG. 13 Global Others Market Revenue, 2012 - 2020 (USD Million)
FIG. 14 Global Corticosteroid Market Revenue, 2012 - 2020 (USD Million)
FIG. 15 Global Anesthetic Market Revenue, 2012 - 2020 (USD Million)
FIG. 16 Global Analgesic Market Revenue, 2012 - 2020 (USD Million)
FIG. 17 Global Antihistamine Market Revenue, 2012 - 2020 (USD Million)
FIG. 18 Global Antimicrobial Market Revenue, 2012 - 2020 (USD Million)
FIG. 19 North America Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Europe Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Asia-Pacific Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 RoW Mouth Ulcers Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 23 Annual Revenue: 3M, 2011 – 2013 (USD Million)*
FIG. 24 Bristol-Myers Squibb Company: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Church & Dwight Co., Inc.: Net Sales, 2011 – 2013 (USD Million)
FIG. 26 Colgate-Palmolive Company: Net Sales, 2011/12 – 2013/14 (USD Million)
FIG. 27 GlaxoSmithKline plc: Annual Sales, 2011 – 2013 (USD Million)
FIG. 28 Pfizer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 Taro Pharmaceutical Industries Ltd: Net Sales, 2011 – 2013 (USD Million)

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Mouth Ulcers Treatment Market (2013 & 2020)
TABLE 3 Global Mouth Ulcer Treatments Market Revenue, by Formulation, 2012 - 2020 (USD Million)
TABLE 4 Global Mouth Ulcer Treatments Market Revenue, by Indication, 2012 - 2020 (USD Million)
TABLE 5 Global Mouth Ulcer Treatments Market Revenue, by Drug Class, 2012 - 2020 (USD Million)
TABLE 6 Global Mouth Ulcers Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million)

Mouth ulcers, also known as aphthous ulcers, are painful open sores or lesions that are mostly found inside the mouth, either singly or in clusters. Mouth ulcers are extremely common and the prevalence rate is 2% to 60% among the global population. Various classes of drugs such as corticosteroid, analgesic, anesthetic, antihistamine and antimicrobial are utilized for the treatment of mouth ulcers. This research report on mouth ulcers treatment market explains various advancements occurring in this market and analyzes the global mouth ulcers treatment market by formulation, indication, drug class as well as geographic regions. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner.  
 
A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global mouth ulcers treatment market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis and key players’ heat map analysis in 2013 in the mouth ulcers treatment market. Mouth ulcers treatment market report also explains about positive and negative factors for each of the formulations, drug class as well as indications. 
 
The global market for mouth ulcers is segmented based on formulation into mouthwash, gels, spray and lozenge. The market for these formulations has been extensively analyzed based on consistency, effectiveness and sales revenue of the various formulations developed by the manufacturers. The market size and forecast in terms of USD million for each formulation has been provided for the period 2012 to 2020. The report on the mouth ulcers treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment and sub segment for the forecast period 2014 to 2020, considering 2013 as the base year. 
 
In addition, the global market for mouth ulcers treatment is segmented based on the indication. The segment is categorized into aphthous stomatitis, oral lichen planus and others. The market for these indications of mouth ulcers treatment has been extensively analyzed based on demand of various treatment options among population. The market size and forecast in terms of USD million for each segment has been provided for the period 2012 to 2020. The report on the mouth ulcers treatment market also provides % compounded annual growth rate (CAGR) for each market segment and sub segment for the forecast period 2014 to 2020, considering 2013 as the base year.  
 
Likewise, the global market for mouth ulcers is segmented based on drug class into corticosteroid, anesthetic, analgesic, antihistamine and antimicrobial. The market for these drug classes has been extensively analyzed based on consistency, effectiveness and sales revenue of the various classes developed by the manufacturers. The market size and forecast in terms of USD million for each drug class has been provided for the period 2012 to 2020. The report on the mouth ulcers treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment and sub segment for the forecast period 2014 to 2020, considering 2013 as the base year.  
 
Geographically, the mouth ulcers treatment market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The research study also incorporates the competitive scenario of major players in these regions. 
 
A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market share. The report concludes with the profiles of major players in the mouth ulcers treatment market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes include 3M Healthcare, Bristol Meyer Squibb Company, ECR Pharmaceuticals, GlaxoSmithKline plc and Church & Dwight Co, Inc. among others.  
 
The global mouth ulcers treatment market is segmented as follows:
  • Mouth Ulcers Treatment Market, by Formulation
    • Mouthwash
    • Gel
    • Spray
    • Lozenge
  • Mouth Ulcers Treatment Market, by Indication
    • Aphthous Stomatitis
    • Oral Lichen Planus
    • Others
  • Mouth Ulcers Treatment Market, by Drug Class
    • Corticosteroid
    • Anesthetic
    • Analgesic
    • Antihistamine
    • Antimicrobial
  • Mouth Ulcers Treatment Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World


 
 
Back To Top